Risk factors for community acquired urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing Escherichia coli in children: a case control study

References

• Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14:933–951.
   PubMed Web of Science ®Google Scholar
• Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8:159–166.
   PubMed Web of Science ®Google Scholar
• Arslan H, Azap OK, Ergonul O, et al. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother. 2005;56:914–918.
   PubMed Web of Science ®Google Scholar
• Doi Y, Adams J, O’Keefe A, et al. Community-acquired extended-spectrum beta-lactamase producers, United States. Emerg Infect Dis. 2007;13:1121–1123.
   PubMed Web of Science ®Google Scholar
• Meier S, Weber R, Zbinden R, et al. Extended-spectrum beta-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection. 2011;39:333–340.
   PubMed Web of Science ®Google Scholar
• Pitout JD, Nordmann P, Laupland KB, et al. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother. 2005;56:52–59.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Bano J, Navarro MD, Romero L, et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in non-hospitalized patients. J Clin Microbiol. 2004;42:1089–1094.
   PubMed Web of Science ®Google Scholar
• Colodner R, Rock W, Chazan B, et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis. 2004;23:163–167.
   PubMed Web of Science ®Google Scholar
• Calbo E, Romani V, Xercavins M, et al. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemother. 2006;57:780–783.
   PubMed Web of Science ®Google Scholar
• Goyal D, Dean N, Neill S, et al. Risk factors for community-acquired extended-spectrum beta-lactamase-producing Enterobacteriaceae infections-a retrospective study of symptomatic urinary tract infections. Open Forum Infect Dis. 2019;6:ofy357.
   PubMed Web of Science ®Google Scholar
• Zaoutis TE, Goyal M, Chu JH, et al. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children. Pediatrics. 2005;115:942–949.
   PubMed Web of Science ®Google Scholar
• Kuo KC, Shen YH, Hwang KP. Clinical implications and risk factors of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection in children: a case-control retrospective study in a medical center in southern Taiwan. J Microbiol Immunol Infect. 2007;40:248–254.
   PubMedGoogle Scholar
• Topaloglu R, Er I, Dogan BG, et al. Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children. Pediatr Nephrol. 2010;25:919–925.
   PubMed Web of Science ®Google Scholar
• Madhi F, Jung C, Timsit S, et al. Febrile urinary-tract infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: a French prospective multicenter study. PloS one. 2018;13:e0190910.
   PubMed Web of Science ®Google Scholar
• Kizilca O, Siraneci R, Yilmaz A, et al. Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children. Pediatr Int. 2012;54:858–862.
   PubMed Web of Science ®Google Scholar
• Uyar Aksu N, Ekinci Z, Dundar D, et al. Childhood urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria: Risk factors and empiric therapy. Pediatrics Int. 2017;59:176–180.
   PubMed Web of Science ®Google Scholar
• Logan LK, Braykov NP, Weinstein RA, et al. Extended-Spectrum beta-lactamase-producing and third-generation cephalosporin-resistant Enterobacteriaceae in children: trends in the United States, 1999-2011. J Pediatric Infect Dis Soc. 2014;3:320–328.
   PubMedGoogle Scholar
• BD Phoenix TM NMIC/ID Panel [Package Insert]. Becton, Sparks, MD, USA: Dickinson and Company; 2009.
   Google Scholar
• Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18:657–686.
   PubMed Web of Science ®Google Scholar
• Doi Y, Park YS, Rivera JI, et al. Community-associated extended-spectrum beta-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis. 2013;56:641.
   PubMed Web of Science ®Google Scholar
• Perez Heras I, Sanchez-Gomez JC, Beneyto-Martin P, et al. Community-onset extended-spectrum β-lactamase producing Escherichia coli in urinary tract infections in children from 2015 to 2016: prevalence, risk factors, and resistances . Medicine (Baltimore).. 2017;96:e8571.
   PubMed Web of Science ®Google Scholar
• Fan NC, Chen HH, Chen CL, et al. Rise of community-onset urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli in children. J Microbiol Immunol Infect. 2014;47:399–405.
   PubMedGoogle Scholar
• Doi Y, Iovleva A, Bonomo RA. The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world. J Travel Med. 2017;24:S44–S51.
   PubMed Web of Science ®Google Scholar
• Karanika S, Karantanos T, Arvanitis M, et al. Fecal colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae and risk factors among healthy individuals: a systematic review and meta-analysis. Clin Infect Dis. 2016;63:310–318.
   PubMed Web of Science ®Google Scholar
• Kantele A, Laaveri T, Mero S, et al. Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis. 2015;60:837–846.
   PubMed Web of Science ®Google Scholar
• Tangden T, Cars O, Melhus A, et al. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother. 2010;54:3564–3568.
   PubMed Web of Science ®Google Scholar
• Ruppe E, Armand-Lefevre L, Estellat C, et al. High rate of acquisition but short duration of carriage of multidrug-resistant Enterobacteriaceae after travel to the tropics. Clin Infect Dis. 2015;61:593–600.
   PubMed Web of Science ®Google Scholar
• Ravensbergen SJ, Berends M, Stienstra Y, et al. High prevalence of MRSA and ESBL among asylum seekers in the Netherlands. PLoS One. 2017;12:e0176481.
   PubMed Web of Science ®Google Scholar
• Ena J, Arjona F, Martinez-Peinado C, et al. Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Urology. 2006;68:1169–1174.
   PubMed Web of Science ®Google Scholar
• Knudsen PK, Brandtzaeg P, Hoiby EA, et al. Impact of extensive antibiotic treatment on faecal carriage of antibiotic-resistant Enterobacteria in children in a low resistance prevalence setting. PloS one. 2017;12:e0187618.
   PubMed Web of Science ®Google Scholar
• Donskey CJ. Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative bacilli. Clin Infect Dis. 2006;43:S62–S69.
   PubMed Web of Science ®Google Scholar
• Carattoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother. 2009;53:2227–2238.
   PubMed Web of Science ®Google Scholar
• Lob SH, Nicolle LE, Hoban DJ, et al. Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010-2014. Diagn Microbiol Infect Dis. 2016;85:459–465.
   PubMed Web of Science ®Google Scholar
• Soltani R, Ehsanpoor M, Khorvash F, et al. Antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing bacteria causing nosocomial urinary tract infections in an Iranian referral teaching hospital. J Res Pharm Pract. 2014;3:6–11.
   PubMedGoogle Scholar
• Azap ÖK, Arslan H, Şerefhanoğlu K, et al. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect. 2010;16:147–151.
   PubMed Web of Science ®Google Scholar